BUSINESS PITCH
Elevator Pitch
In Canada, the number of prescriptions for oral contraceptives has steadily dropped. Canadian pharmacies dispensed 1.17 million fewer prescriptions in 2015 than 2011. The decrease in the use of contraceptive pills is a shift in preferences among Canadian women as new alternatives such as estrogen-free and non-hormonal methods become available on the market. This trend follows a growing emphasis on natural health. OvuGuard, a high tech fertility monitor is the option for women of millennial age group to detect the ovulation period in real time. Women and partners can decide to prevent or initiate pregnancy without putting into the women's bodies the artificial hormones in contraceptive pills and injections.
Product / Service Description
OvuGuard is a medical device fertility monitor that can be used alone or connected to smartphone by accurately and automatically detecting the ovulation period. OvuGuard is a health risk-free, reliable device for preventing the side effects of artificial hormones in the woman’s body contained in artificial contraceptive products. OvuGuard users are continuously engage through the cloud web services integrating fertility with health, exercise, stress, sleep level and nutrition. The cloud based software will provide actionable data and recommendation to effect changes on users lifestyle. The cloud platform is named Family & Lifestyle Planner powered by Artificial Intelligence (AI) Lifestyle Metrics Engine.
Competitive Advantage
OvuGuard is a medical device fertility monitor with two (2) programmed digital sensors automatically detecting, without user’s inputs the biomarkers Body Basal Temperature (BBT) and condition/quality of cervical mucus. It has two model, a stand-alone and a model connected to smartphone and cloud web services. The medical device can be used in real time without user's inputs. It accurately detects the 5-day ovulation period that partners can decide to prevent or initiate pregnancy. OvuGuard is a certified medical device with proprietary Body Basal Temperature (BBT) and cervical mucus sensors designed for mass adoption and mass market. A medical device has niche market, but not OvuGuard.
Customer Problem and Market Opportunity
OvuGuard makes available and affordable the high-tech fertility monitor to millions of women of reproductive age who could make smarter decisions about whether and when to have children. The medically certified fertility monitor gives women the freedom and empowerment to control their bodies, take charge of fertility and harness the power of the cloud. The Family & Lifestyle Planner is a new cloud-based Internet platform for OvuGuard users designed to change their lifestyle for preventative medicine, optimization of health and science literacy.
Some women have become uncomfortable with putting synthetic hormones in their bodies. The World Health Organizations (WHO) has declared artificial hormones as a steroid, and therefore a carcinogen. A large-scale longitudinal study published in 2015 in the journal JAMA Psychiatry, part of American Medical Association network, suggests hormonal contraception could cause depression. The study analyzed the one million women study for 14 years in Denmark that confirmed hormonal contraception could cause depression. The pill’s instructions for use list various risks and side effects, from PMS (premenstrual syndrome)-like to decreased libido, migraine, an increased risk of breast cancer and blood clots. OvuGuard also prevents abortion with unwanted pregnancy.